Indication
Coronary Microvascular Dysfunction
3 clinical trials
4 products
1 drug
Product
CLBS16Clinical trial
A Double-Blind, Randomized, Placebo-Controlled Clinical Study to Evaluate the Efficacy and Safety of CLBS16 in Subjects With Coronary Microvascular Dysfunction and Without Obstructive Coronary Artery DiseaseStatus: Terminated, Estimated PCD: 2022-09-28
Product
PlaceboClinical trial
Study of Microvascular Dysfunction, Coronary Flow Reserve and Cardioprotective Effect of Early Intravenously Administration of Esmolol in Patients With Myocardial InfarctionStatus: Recruiting, Estimated PCD: 2029-01-29
Product
EsmololClinical trial
Vericiguat in Patients With Metabolic Syndrome and Coronary Vascular DysfunctionStatus: Recruiting, Estimated PCD: 2025-06-16
Product
VericiguatDrug
Varlilumab